Refine Search
(3)
(12)
(27)
(27)

NEW Insulin Resistance - Pipeline Review, H1 2019

  • $2,000
  • March 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2019’, provides an overview of the Insulin Resistance pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Insulin ...

Amyloidosis - Pipeline Review, H1 2019

  • $2,000
  • February 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Amyloidosis - Pipeline Review, H1 2019’, provides an overview of the Amyloidosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Amyloidosis, complete ...

Phenylketonuria (PKU) - Pipeline Review, H1 2019

  • $2,000
  • January 2019
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Phenylketonuria (PKU) - Pipeline Review, H1 2019’, provides an overview of the Phenylketonuria (PKU) pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ph...

Diabetic Foot Ulcers - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H2 2018’, provides an overview of the Diabetic Foot Ulcers pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Diabetic Neuropathy - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Neuropathy - Pipeline Review, H2 2018’, provides an overview of the Diabetic Neuropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diabet...

Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Homozygous Familial Hypercholesterolemia (HoFH) - Pipeline Review, H2 2018’, provides an overview of the Homozygous Familial Hypercholesterolemia (HoFH) pipeline landscape.

The report provides comprehensive info...

Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2018

  • $2,000
  • November 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Heterozygous familial hypercholesterolemia (heFH) - Pipeline Review, H2 2018’, provides an overview of the Heterozygous familial hypercholesterolemia (heFH) pipeline landscape.

The report provides comprehensive ...

Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Osteoporosis, comple...

Post Menopausal Osteoporosis - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Post Menopausal Osteoporosis - Pipeline Review, H2 2018’, provides an overview of the Post Menopausal Osteoporosis pipeline landscape.

The report provides comprehensive information on the therapeutics under deve...

Pompe Disease - Pipeline Review, H2 2018

  • $2,000
  • October 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Pompe Disease - Pipeline Review, H2 2018’, provides an overview of the Pompe Disease pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Pompe Disease, com...

Hyperuricemia - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hyperuricemia - Pipeline Review, H2 2018’, provides an overview of the Hyperuricemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Hyperuricemia, com...

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018

  • $2,000
  • September 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H2 2018’, provides an overview of the Proliferative Diabetic Retinopathy (PDR) pipeline landscape.

The report provides comprehensive information on the...

Dyslipidemia - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H2 2018’, provides an overview of the Dyslipidemia pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Dyslipidemia, comple...

Diabetic Nephropathy - Pipeline Review, H2 2018

  • $2,000
  • August 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2018’, provides an overview of the Diabetic Nephropathy pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Diab...

Diabetic Macular Edema - Pipeline Review, H2 2018

  • $2,000
  • July 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Diabetic Macular Edema - Pipeline Review, H2 2018’, provides an overview of the Diabetic Macular Edema pipeline landscape.

The report provides comprehensive information on the therapeutics under development for ...